tiprankstipranks
Trending News
More News >
Biorem Inc (TSE:BRM)
:BRM
Canadian Market

Biorem Inc (BRM) Technical Analysis

Compare
13 Followers

Summary of all the Indicators

Overall Consensus
Buy
14Bullish
3Neutral
5Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Biorem Inc’s (BRM) Moving Averages Convergence Divergence (MACD) indicator is 0.08, suggesting Biorem Inc is a Sell.
Biorem Inc’s (BRM) 20-Day exponential moving average is 2.20, while Biorem Inc’s (BRM) share price is C$2.37, making it a Buy.
Biorem Inc’s (BRM) 50-Day exponential moving average is 2.15, while Biorem Inc’s (BRM) share price is C$2.37, making it a Buy.

Biorem Inc (BRM) Pivot Points

Jul 06, 2025, 08:11 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2.04
2.11
2.27
2.34
2.50
2.57
2.73
Fibonacci
2.11
2.20
2.26
2.34
2.43
2.49
2.57
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Biorem Inc (BRM) Moving Averages

Jul 06, 2025, 08:11 AM
Period
Simple
Exponential
MA5
2.29Buy
2.32Buy
MA10
2.26Buy
2.27Buy
MA20
2.18Buy
2.20Buy
MA50
2.04Buy
2.15Buy
MA100
2.23Buy
2.23Buy
MA200
2.51Sell
2.35Buy
Biorem Inc’s (BRM) 10-Day exponential moving average is 2.27, while Biorem Inc’s (BRM) share price is C$2.37, making it a Buy.
Biorem Inc’s (BRM) 100-Day exponential moving average is 2.23, while Biorem Inc’s (BRM) share price is C$2.37, making it a Buy.
Biorem Inc’s (BRM) stock price is C$2.37 and Biorem Inc’s (BRM) 50-day simple moving average is 2.04, creating a Buy signal.
Biorem Inc’s (BRM) stock price is C$2.37 and Biorem Inc’s (BRM) 100-day simple moving average is 2.23, creating a Buy signal.
Biorem Inc’s (BRM) stock price is C$2.37 and Biorem Inc’s (BRM) 200-day simple moving average is 2.51, creating a Sell signal.

Biorem Inc (BRM) Technical Indicators

Jul 06, 2025, 08:11 AM
Name
Value
Implied Action
RSI (14)
62.14
Neutral
STOCH (9,6)
79.56
Neutral
STOCHRSI (14)
84.17
Sell
MACD (12,26)
0.08
Sell
ADX (14)
18.83
Buy
Williams %R
-12.20
Sell
CCI (14)
114.39
Sell
ATR (14)
0.16
-
Ultimate Oscillator
69.31
Neutral
ROC
8.22
Buy
Biorem Inc’s (BRM) Relative Strength Index (RSI) is 62.14, creating a Neutral signal.
Biorem Inc’s (BRM) Trend Strength Indicator (ADX) is 18.83, creating a Buy signal.
Biorem Inc’s (BRM) Commodity Channel Index (CCI) is 114.39, creating a Sell signal.
Biorem Inc’s (BRM) Price Rate of Change (ROC) is 8.22, creating a Buy signal.

FAQ

Is BRM a Buy, Hold, or Sell?
Based on BRM’s technical indicators, BRM is a Buy.
    What is BRM’s RSI (14)?
    BRM’s RSI (14) is 62.14, which suggests BRM is a Neutral.
      What is BRM’s MACD?
      BRM’s MACD is 0.08, which suggests BRM is a Sell.
        What is BRM’s 5-day moving average?
        BRM’s 5-day moving average is 2.29, which suggests BRM is a Buy.
          What is BRM’s 20-day moving average?
          BRM 20-day moving average is 2.18, which suggests BRM is a Buy.
            What is BRM’s 50-day moving average?
            BRM’s 50-day moving average is 2.04, which suggests BRM is a Buy.
              What is BRM’s 200-day moving average?
              BRM’s 200-day moving average is 2.51, which suggests BRM is a Sell.
                What is BRM’s Williams % R (14)?
                BRM’s Williams % R (14) is -12.20, which suggests BRM is a Sell.
                  What is BRM’s CCI (14)?
                  BRM’s CCI (14) is 114.39, which suggests BRM is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis